Tag : Stocks

image_pdfimage_print

The shares of leading networking solutions company NVIDIA (NVDA) have been plummeting due to bearish market sentiment amid several macroeconomic headwinds. So, because the markets remain under pressure as the Fed gears up to increase benchmark interest rates again this month, will NVDA be able to regain forward momentum soon? Read more to find out. ..

Leggi tutto

Shares of UiPath Inc. (PATH) are down more than 35% in price over the past month. Although rising demand for robotic process automation has increased PATH’s sales, the question is, will its shares rebound in the near term, given worries about increasing competition from leading companies in the automation services industry? Let’s discuss. shutterstock.com – ..

Leggi tutto

Signet Jewelers (SIG) posted solid fundamental performance thanks to robust growth in its e-commerce business and smooth progress in its Inspiring Brilliance strategy in its fiscal fourth quarter. In addition, the company is striving to strengthen its data analytics skills and is looking forward to bringing the connected commerce concept to its next phase of ..

Leggi tutto

The S&P 500 (SPY) had a nice bounce and remains above its key level. However, the market faces some serious challenges in terms of inflation, a hawkish Fed, and now a possible slowdown in growth. Read on to find out how we are navigating this tricky market environment. shutterstock.com – StockNews We’ve seen a deterioration ..

Leggi tutto

Entertainment services provider Netflix’s (NFLX) shares have dipped since the company reported weak first-quarter earnings results. But can they rebound on the company’s ability to leverage its broad portfolio of products and services? Read on to learn our view. shutterstock.com – StockNews Netflix Inc. (NFLX) in Los Gatos, Calif., offers TV series, documentaries, feature films, ..

Leggi tutto

Thanks to the global COVID-19 vaccination drive and inelastic demand for healthcare, biotechnology stocks have been outperforming the broader markets so far this year. Because this trend will likely continue, we think investing in popular biotech stocks Regeneron Pharmaceuticals (REGN), Exelixis (EXEL), Jazz Pharmaceuticals (JAZZ), Alkermes (ALKS), and Incyte Corp. (INCY) could be wise. Let’s ..

Leggi tutto